KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Liabilities and Shareholders Equity: 2009-2025

Historic Liabilities and Shareholders Equity for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Sep 2025 value amounting to $39.9 billion.

  • Teva Pharmaceutical Industries' Liabilities and Shareholders Equity fell 4.55% to $39.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 billion, marking a year-over-year decrease of 6.86%. This contributed to the annual value of $39.3 billion for FY2024, which is 9.55% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Liabilities and Shareholders Equity stood at $39.9 billion for Q3 2025, which was down 0.69% from $40.1 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' 5-year Liabilities and Shareholders Equity high stood at $49.2 billion for Q2 2021, and its period low was $38.4 billion during Q1 2025.
  • Moreover, its 3-year median value for Liabilities and Shareholders Equity was $41.8 billion (2024), whereas its average is $41.4 billion.
  • Data for Teva Pharmaceutical Industries' Liabilities and Shareholders Equity shows a maximum YoY declined of 11.43% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Liabilities and Shareholders Equity stood at $47.7 billion in 2021, then decreased by 7.67% to $44.0 billion in 2022, then fell by 1.21% to $43.5 billion in 2023, then fell by 9.55% to $39.3 billion in 2024, then fell by 4.55% to $39.9 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $39.9 billion for Q3 2025, versus $40.1 billion for Q2 2025 and $38.4 billion for Q1 2025.